LRRK2 and Parkinson disease: Similarly, early biomarker studies, assessing LRRK2 auto-phosphorylation (pS1292-LRRK2) in urinary exosomes, have indicated that LRRK2 activity may be elevated during the clinical progression of LRRK2-associated, as well as idiopathic, PD (iPD)2,3.